Goldman Sachs Group, Inc. (GS) is set to announce its fourth-quarter earnings before the opening bell on January 16, 2024. Analysts are expecting the bank to report earnings of $3.41 per share, compared to $3.32 per share in the same period last year. Revenue is projected to reach $10.80 billion, up from $10.59 billion in the previous year.
Recently, Goldman Sachs Asset Management disclosed the closure of the West Street Life Sciences I fund, which exceeded its fundraising target with $650 million in equity commitments. This indicates strong investor interest in the fund and reflects the company’s focus on innovation in the life sciences sector.
Despite these positive developments, Goldman Sachs shares fell by 0.5% and closed at $377.75 on Friday. This decline may be influenced by various factors, including market trends or investor sentiment.
For investors seeking more information on analyst ratings, they can access the latest ratings on the Analyst Stock Ratings page of Benzinga. The page allows readers to sort ratings by stock ticker, company name, analyst firm, rating change, or other variables.
To provide further insights into the company’s performance, let’s take a look at how Benzinga’s most accurate analysts have rated Goldman Sachs in the recent period:
– UBS analyst Brennan Hawken maintained a Buy rating and raised the price target from $382 to $440 on January 9, 2024. This analyst has an accuracy rate of 69%.
– Morgan Stanley analyst Betsy Graseck maintained an Equal-Weight rating and increased the price target from $329 to $333 on December 4, 2023. This analyst has an accuracy rate of 60%.
– Oppenheimer analyst Chris Kotowski maintained an Outperform rating and raised the price target from $447 to $468 on November 16, 2023. This analyst has an accuracy rate of 74%.
– JMP Securities analyst Devin Ryan reiterated a Market Outperform rating with a price target of $440 on October 18, 2023. This analyst has an accuracy rate of 71%.
– Citigroup analyst Keith Horowitz maintained a Neutral rating and lowered the price target from $400 to $380 on September 21, 2023. This analyst has an accuracy rate of 74%.
It is important for investors to consider these ratings alongside their own research and analysis before making any investment decisions.
In conclusion, Goldman Sachs Group is expected to release its fourth-quarter earnings, with analysts projecting positive results. The closure of the West Street Life Sciences I fund with strong equity commitments further highlights the company’s focus on innovation. However, recent declines in the company’s stock price may require further investigation. Investors can refer to Benzinga’s analyst ratings for additional insights.
